Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
'Whites Must Run!': EFF Rioters In South Africa Attack White Parent Outside School
Emma Watson Writes Open Letter Apologizing For Her 'White Privilege'
Poll: 58% Oppose Shutting Down Govt Over DACA Illegal Aliens
'Blaxit': African Americans Moving to Africa to Escape Racism
At Dems' Request, Twitter to 'Notify' 677,775 Users If They Ever Tweeted a 'Russian-Linked Account'
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.